Oxygenta Pharmaceutical Ltd

Oxygenta Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Oxygenta Pharmaceutical Ltd

₹ 49.6 0.22%
02 Jun - close price
ssorganics.co.in BSE: 524636
About

Incorporated in 1990, Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.

Key Points

Products:[1]
Losartan potassium intermediate, Gabapentin intermediate, Antihypertensive drugs, Anti
cancer drugs, Antiulcer drugs, Antiretroviral drugs, Antihypertensive drugs, Antiviral drugs.

Website BSE
  • Market Cap ₹ 183 Cr.
  • Current Price ₹ 49.6
  • High / Low ₹ 134 / 45.3
  • Stock P/E
  • Book Value ₹ -11.5
  • Dividend Yield 0.00 %
  • ROCE -33.4 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's median sales growth is 22.1% of last 10 years

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
8.19 6.86 13.08 9.15 10.55 12.62 14.01 33.21 49.47 15.13 14.30 33.93 49.61
10.44 10.50 15.06 11.63 12.17 14.40 16.18 37.57 51.15 21.96 18.87 38.01 49.49
Operating Profit -2.25 -3.64 -1.98 -2.48 -1.62 -1.78 -2.17 -4.36 -1.68 -6.83 -4.57 -4.08 0.12
OPM % -27.47% -53.06% -15.14% -27.10% -15.36% -14.10% -15.49% -13.13% -3.40% -45.14% -31.96% -12.02% 0.24%
-0.05 -0.13 -0.03 -0.02 0.26 0.02 0.75 0.49 -0.22 0.16 -0.06 0.00 0.17
Interest 0.94 0.29 0.34 0.36 0.59 0.41 0.69 0.39 2.13 0.63 0.95 1.39 1.81
Depreciation 0.85 0.50 0.83 0.69 0.64 0.65 0.66 0.71 -0.23 0.85 0.86 0.86 -0.24
Profit before tax -4.09 -4.56 -3.18 -3.55 -2.59 -2.82 -2.77 -4.97 -3.80 -8.15 -6.44 -6.33 -1.28
Tax % 4.89% 0.00% -0.63% 6.48% -409.27% -51.42% 2.89% -20.72% -43.42% -25.03% -23.45% -23.38% 32.81%
-4.29 -4.56 -3.16 -3.78 8.02 -1.36 -2.85 -3.93 -2.15 -6.11 -4.93 -4.84 -1.70
EPS in Rs -3.02 -1.36 -0.94 -1.13 2.40 -0.38 -0.80 -1.06 -0.58 -1.65 -1.33 -1.31 -0.46
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6 12 8 13 21 14 52 61 31 40 109 113
10 16 13 17 23 22 48 59 38 49 119 128
Operating Profit -4 -4 -5 -4 -2 -8 4 1 -7 -10 -10 -15
OPM % -67% -34% -59% -31% -10% -57% 7% 2% -23% -24% -9% -14%
0 0 1 1 0 4 2 1 -1 0 1 0
Interest 0 1 1 1 1 1 2 1 1 2 2 5
Depreciation 3 1 1 1 1 1 1 2 2 3 1 2
Profit before tax -7 -6 -6 -4 -3 -6 3 -0 -11 -14 -12 -22
Tax % -11% 0% 2% 1% -7% -3% 7% 24% 2% -75% -16% -21%
-6 -6 -6 -5 -3 -6 3 -1 -12 -3 -10 -18
EPS in Rs -5.99 -5.39 -5.70 -4.44 -3.19 -5.68 2.87 -0.43 -8.15 -1.04 -2.62 -4.75
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 25%
5 Years: 17%
3 Years: 54%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -28%
TTM: -87%
Stock Price CAGR
10 Years: 16%
5 Years: %
3 Years: 15%
1 Year: -49%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10 10 10 10 10 10 10 14 14 33 37 37
Reserves -26 -32 -38 -42 -45 -51 -48 -49 -60 -54 -62 -80
15 17 19 19 22 27 48 52 68 57 62 110
19 24 27 30 34 33 24 14 32 26 46 53
Total Liabilities 18 20 19 17 21 19 34 31 54 63 83 120
12 13 12 12 12 11 16 20 28 29 40 48
CWIP 0 0 0 0 0 0 1 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
6 7 6 5 9 7 17 11 26 34 44 72
Total Assets 18 20 19 17 21 19 34 31 54 63 83 120

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-4 1 1 1 -8 -3 -2 -2 -2 -13 3 -28
1 -2 -1 -0 -1 -0 -7 -5 -10 -4 -11 -14
3 1 0 -1 8 3 9 6 11 17 9 43
Net Cash Flow 0 -0 0 -0 0 0 0 -0 -0 -0 0 0
Free Cash Flow -7 -1 -0 1 -8 -3 -8 -7 -11 -17 -9 -41
CFO/OP 104% -20% -13% -33% 396% 35% -37% -106% 23% 135% -28% 182%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 38 44 39 14 9 11 11 10 120 68 17 32
Inventory Days 84 41 122 57 121 100 121 56 178 149 78 105
Days Payable 1,800 667 599 396 203 190 137 50 362 249 113 174
Cash Conversion Cycle -1,678 -582 -439 -325 -73 -79 -5 16 -64 -32 -18 -37
Working Capital Days -616 -454 -512 -438 -164 -275 -14 8 -94 -89 -184 -119
ROCE % -1% -47% -42% -25% -33%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Coal Consumption
MT

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
Count
Power and Fuel Consumption
Lakh Units
Installed Capacity (Bulk Drugs)
MTPA

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
26.80% 29.73% 29.73% 29.73% 33.68% 53.28% 51.12% 51.12% 57.95% 57.95% 55.93% 56.53%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
73.18% 70.24% 70.24% 70.24% 66.28% 46.69% 48.84% 48.84% 42.02% 42.01% 44.05% 43.44%
No. of Shareholders 8,9878,9729,05110,1029,97010,15410,10710,03010,09410,17910,21510,205

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports